06/11/2025 - Press release
A systematic review of published studies on service coverage for these conditions in adults, published in The Lancet Regional Health - Europe, reveals this gap. Overall, there is little information about the capacity to provide care for people with mental disorders across European countries. Existing data show great disparities between nations and generally low coverage for nearly all disorders. These figures put at risk the World Health Organization's goal of increasing coverage for these patients by 50% by 2030.
04/11/2025 - General information
The Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team at Hospital del Mar has received a competitive international grant awarded by the pharmaceutical company Pfizer, as part of the "Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations." The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.
Més informació "Pfizer International Grant for a Project at Hospital del Mar on Antibiotic Therapy"
31/10/2025 - Press release
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave differently in TRD compared with non-resistant patients. The study reports the first results of the PROMPT consortium, which aims to combine clinical and molecular data using machine learning to predict which patients are at risk of developing TRD.
Més informació "Treatment-resistant depression identified as a distinct molecular subtype"
30/10/2025 - Events
For a project in the field of genomics of chronic lymphocytic leukemia. The grant was awarded by the Spanish Group of Chronic Lymphocytic Leukemia and presented during the congress of the Spanish Society of Hematology and Hemotherapy.
29/10/2025 - Events
The two institutions are leading a joint Cell Therapy and Substances of Human Origin (SoHO) Programme, which aims to become a key player in the field of these new treatments in Catalonia. The Minister of Health, Olga Pané, the Director General of the Department of Research, Teresa Sanchís, and the Director General of the BST, Anna Millan, took part in the presentation of the programme. They also visited the new cell culture laboratory at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, which will strengthen the cell therapy capabilities of both centres.
22/10/2025 - General information
The Hemodynamics Unit of the Cardiology Department at Hospital del Mar took part in a study published in the New England Journal of Medicine. The study demonstrates that one month after undergoing treatment for a myocardial infarction, patients can safely continue therapy with a single antiplatelet drug without added risk.
16/10/2025 - Press release
Greater exposure of mothers to airborne particulate matter during pregnancy is linked to lower levels of brain myelination in newborns. This is highlighted by the first study to measure neonatal brain myelination using magnetic resonance imaging (MRI). Published in the journal Environment International, it is the result of a collaboration between Hospital del Mar and ISGlobal. The research shows that prenatal exposure to fine particles (PM2.5) is associated with slower brain maturation during the first month of life. Myelination is a key marker of brain development.
15/10/2025 - Events
The project, conducted jointly with the Barcelonaβeta Research Center and whose results were published in The Journal of Prevention of Alzheimer's Disease, involved around one hundred volunteers who were followed for more than a year. To mark the end of five years of collaboration-beginning with the recruitment of participants-the volunteers took part in an event where the study's findings were presented. It was a way to return the results to those who made the research possible.
Més informació "The PENSA study concludes with a farewell celebration for its participants"
10/10/2025 - Press release
Stress sensitivity increases the frequency, intensity, and variability of suicidal thoughts among the university community. These are the findings of a longitudinal study coordinated by the Hospital del Mar Research Institute and Pompeu Fabra University, which analyses survey data from more than 700 university students. The study defines, for the first time, three degrees of passive suicidal ideation according to their frequency, intensity and increasing variability. Taking stress sensitivity into account could have an impact on suicide prevention.
07/10/2025 - Institutional news
The new edition of this prestigious list includes 38 professionals currently or formerly affiliated with the centre and its research institute. Nearly forty researchers from Hospital del Mar and the Hospital del Mar Research Institute appear in the World's Top 2% Scientist ranking, which features the most influential scientists in the world. This list, compiled by Stanford University, identifies the most cited researchers across various disciplines. It is divided into 22 fields of knowledge and 174 subfields, and includes 100,000 people - representing the top 2% of the world's eight million active scientists.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
